Selected research
Industry Research
Genome Chip Industry Research Report 2026
Market perspective
The global Genome Chip market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Genome Chip is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Genome Chip is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Genome Chip include Illumnia, Thermo Fisher, Agilent, Scienion AG, SCHOTT, Arrayit, Standard BioTools, QIAGEN and GeneCopoeia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Genome Chip market in terms of revenue (US$ million) and, where applicable, sales volume (k pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genome Chip Market by Company
Illumnia
Thermo Fisher
Agilent
Scienion AG
SCHOTT
Arrayit
Standard BioTools
QIAGEN
GeneCopoeia
Oxford Gene Technology
Axela Biosciences
Genome Chip Segment by Type
Oligonucleotide DNA Chip
Complementary DNA Chip
Genome Chip Segment by Application
Research Centers
Clinical
Commercial Molecular Diagnostic
Others
Genome Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Genome Chip manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Genome Chip by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Genome Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oligonucleotide DNA Chip
- Complementary DNA Chip
Applications
- Research Centers
- Clinical
- Commercial Molecular Diagnostic
- Others
Companies covered
- Illumnia
- Thermo Fisher
- Agilent
- Scienion AG
- SCHOTT
- Arrayit
- Standard BioTools
- QIAGEN
- GeneCopoeia
- Oxford Gene Technology
- Axela Biosciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Genome Chip Market Size (2021-2032)
- 2.2.2 Global Genome Chip Sales (2021-2032)
- 2.2.3 Global Genome Chip Market Average Price (2021-2032)
- 2.3 Genome Chip by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oligonucleotide DNA Chip
- 2.3.3 Complementary DNA Chip
- 2.4 Genome Chip by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Research Centers
- 2.4.3 Clinical
- 2.4.4 Commercial Molecular Diagnostic
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Genome Chip Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Genome Chip Sales (k pcs) of Manufacturers (2021-2026)
- 3.3 Global Genome Chip Revenue of Manufacturers (2021-2026)
- 3.4 Global Genome Chip Average Price by Manufacturers (2021-2026)
- 3.5 Global Genome Chip Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Genome Chip, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Genome Chip, Product Type & Application
- 3.8 Global Manufacturers of Genome Chip, Established Date
- 3.9 Global Genome Chip Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Illumnia
- 4.1.1 Illumnia Company Information
- 4.1.2 Illumnia Business Overview
- 4.1.3 Illumnia Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Illumnia Genome Chip Product Portfolio
- 4.1.5 Illumnia Recent Developments
- 4.2 Thermo Fisher
- 4.2.1 Thermo Fisher Company Information
- 4.2.2 Thermo Fisher Business Overview
- 4.2.3 Thermo Fisher Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Genome Chip Product Portfolio
- 4.2.5 Thermo Fisher Recent Developments
- 4.3 Agilent
- 4.3.1 Agilent Company Information
- 4.3.2 Agilent Business Overview
- 4.3.3 Agilent Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Agilent Genome Chip Product Portfolio
- 4.3.5 Agilent Recent Developments
- 4.4 Scienion AG
- 4.4.1 Scienion AG Company Information
- 4.4.2 Scienion AG Business Overview
- 4.4.3 Scienion AG Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Scienion AG Genome Chip Product Portfolio
- 4.4.5 Scienion AG Recent Developments
- 4.5 SCHOTT
- 4.5.1 SCHOTT Company Information
- 4.5.2 SCHOTT Business Overview
- 4.5.3 SCHOTT Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SCHOTT Genome Chip Product Portfolio
- 4.5.5 SCHOTT Recent Developments
- 4.6 Arrayit
- 4.6.1 Arrayit Company Information
- 4.6.2 Arrayit Business Overview
- 4.6.3 Arrayit Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Arrayit Genome Chip Product Portfolio
- 4.6.5 Arrayit Recent Developments
- 4.7 Standard BioTools
- 4.7.1 Standard BioTools Company Information
- 4.7.2 Standard BioTools Business Overview
- 4.7.3 Standard BioTools Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Standard BioTools Genome Chip Product Portfolio
- 4.7.5 Standard BioTools Recent Developments
- 4.8 QIAGEN
- 4.8.1 QIAGEN Company Information
- 4.8.2 QIAGEN Business Overview
- 4.8.3 QIAGEN Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 QIAGEN Genome Chip Product Portfolio
- 4.8.5 QIAGEN Recent Developments
- 4.9 GeneCopoeia
- 4.9.1 GeneCopoeia Company Information
- 4.9.2 GeneCopoeia Business Overview
- 4.9.3 GeneCopoeia Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GeneCopoeia Genome Chip Product Portfolio
- 4.9.5 GeneCopoeia Recent Developments
- 4.10 Oxford Gene Technology
- 4.10.1 Oxford Gene Technology Company Information
- 4.10.2 Oxford Gene Technology Business Overview
- 4.10.3 Oxford Gene Technology Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Oxford Gene Technology Genome Chip Product Portfolio
- 4.10.5 Oxford Gene Technology Recent Developments
- 4.11 Axela Biosciences
- 4.11.1 Axela Biosciences Company Information
- 4.11.2 Axela Biosciences Business Overview
- 4.11.3 Axela Biosciences Genome Chip Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Axela Biosciences Genome Chip Product Portfolio
- 4.11.5 Axela Biosciences Recent Developments
5 Global Genome Chip Market Scenario by Region
- 5.1 Global Genome Chip Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Genome Chip Sales by Region: 2021-2032
- 5.2.1 Global Genome Chip Sales by Region: 2021-2026
- 5.2.2 Global Genome Chip Sales by Region: 2027-2032
- 5.3 Global Genome Chip Revenue by Region: 2021-2032
- 5.3.1 Global Genome Chip Revenue by Region: 2021-2026
- 5.3.2 Global Genome Chip Revenue by Region: 2027-2032
- 5.4 North America Genome Chip Market Facts & Figures by Country
- 5.4.1 North America Genome Chip Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Genome Chip Sales by Country (2021-2032)
- 5.4.3 North America Genome Chip Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Genome Chip Market Facts & Figures by Country
- 5.5.1 Europe Genome Chip Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Genome Chip Sales by Country (2021-2032)
- 5.5.3 Europe Genome Chip Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Genome Chip Market Facts & Figures by Country
- 5.6.1 Asia Pacific Genome Chip Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Genome Chip Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Genome Chip Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Genome Chip Market Facts & Figures by Country
- 5.7.1 South America Genome Chip Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Genome Chip Sales by Country (2021-2032)
- 5.7.3 South America Genome Chip Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Genome Chip Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Genome Chip Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Genome Chip Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Genome Chip Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Genome Chip Sales by Type (2021-2032)
- 6.1.1 Global Genome Chip Sales by Type (2021-2032) & (k pcs)
- 6.1.2 Global Genome Chip Sales Market Share by Type (2021-2032)
- 6.2 Global Genome Chip Revenue by Type (2021-2032)
- 6.2.1 Global Genome Chip Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Genome Chip Revenue Market Share by Type (2021-2032)
- 6.3 Global Genome Chip Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Genome Chip Sales by Application (2021-2032)
- 7.1.1 Global Genome Chip Sales by Application (2021-2032) & (k pcs)
- 7.1.2 Global Genome Chip Sales Market Share by Application (2021-2032)
- 7.2 Global Genome Chip Revenue by Application (2021-2032)
- 7.2.1 Global Genome Chip Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Genome Chip Revenue Market Share by Application (2021-2032)
- 7.3 Global Genome Chip Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Genome Chip Value Chain Analysis
- 8.1.1 Genome Chip Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Genome Chip Production Mode & Process
- 8.2 Genome Chip Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Genome Chip Distributors
- 8.2.3 Genome Chip Customers
9 Global Genome Chip Analyzing Market Dynamics
- 9.1 Genome Chip Industry Trends
- 9.2 Genome Chip Industry Drivers
- 9.3 Genome Chip Industry Opportunities and Challenges
- 9.4 Genome Chip Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst